{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T07:08:22Z","timestamp":1768460902306,"version":"3.49.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","cancergeneticsjournal.org","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Genetics"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.cancergen.2015.11.002","type":"journal-article","created":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T14:00:19Z","timestamp":1448978419000},"page":"11-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Papillary renal cell carcinoma with a somatic mutation in MET in a patient with autosomal dominant polycystic kidney disease"],"prefix":"10.1016","volume":"209","author":[{"given":"Wanying","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian Y.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon","family":"Blumenfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alber","family":"Michaeel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian D.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven P.","family":"Salvatore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandip","family":"Kapur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Donahue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Warren O.","family":"Bobb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna","family":"Rennert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergen.2015.11.002_bib0010","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0140-6736(99)06154-1","article-title":"Cancer in patients on dialysis for end-stage renal disease: an international collaborative study","volume":"354","author":"Maisonneuve","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.cancergen.2015.11.002_bib0015","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1093\/ndt\/gfv007","article-title":"Mortality from infections and malignancies in patients treated with renal replacement therapy: data from the ERA-EDTA registry","volume":"30","author":"Vogelzang","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.cancergen.2015.11.002_bib0020","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/01.pas.0000185382.80844.b1","article-title":"Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia","volume":"30","author":"Tickoo","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.cancergen.2015.11.002_bib0025","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1007\/s11255-014-0780-4","article-title":"Renal insufficiency is associated with an increased risk of papillary renal cell carcinoma histology","volume":"46","author":"Woldu","year":"2014","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.cancergen.2015.11.002_bib0030","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ki.2015.59","article-title":"Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: improving Global Outcomes (KDIGO) Controversies Conference","volume":"88","author":"Chapman","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.cancergen.2015.11.002_bib0035","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/nrneph.2015.46","article-title":"The hallmarks of cancer: relevance to the pathogenesis of polycystic kidney disease","volume":"11","author":"Seeger-Nukpezah","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.cancergen.2015.11.002_bib0040","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1038\/sj.onc.1202547","article-title":"Novel mutations of the MET proto-oncogene in papillary renal carcinomas","volume":"18","author":"Schmidt","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.cancergen.2015.11.002_bib0045","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/bcp.12136","article-title":"New treatments for autosomal dominant polycystic kidney disease","volume":"76","author":"Chang","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.cancergen.2015.11.002_bib0050","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1093\/hmg\/ddp165","article-title":"Systems biology of autosomal dominant polycystic kidney disease (ADPKD): computational identification of gene expression pathways and integrated regulatory networks","volume":"18","author":"Song","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cancergen.2015.11.002_bib0055","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/01.ASN.0000046963.60910.63","article-title":"Molecular cytogenetic aberrations in autosomal dominant polycystic kidney disease tissue","volume":"14","author":"Gogusev","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.cancergen.2015.11.002_bib0060","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/humu.20842","article-title":"Novel method for genomic analysis of PKD1 and PKD2 mutations in autosomal dominant polycystic kidney disease","volume":"30","author":"Tan","year":"2009","journal-title":"Hum Mutat"},{"key":"10.1016\/j.cancergen.2015.11.002_bib0065","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2015.1313","article-title":"Whole-exome sequencing of metastatic cancer and biomarkers of treatment response","author":"Beltran","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.cancergen.2015.11.002_bib0070","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1101\/gr.129684.111","article-title":"VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing","volume":"22","author":"Koboldt","year":"2012","journal-title":"Genome Res"},{"key":"10.1016\/j.cancergen.2015.11.002_bib0075","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nbt.2514","article-title":"Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples","volume":"31","author":"Cibulskis","year":"2013","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.cancergen.2015.11.002_bib0080","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/nprot.2012.016","article-title":"Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks","volume":"7","author":"Trapnell","year":"2012","journal-title":"Nat Protoc"},{"key":"10.1016\/j.cancergen.2015.11.002_bib0085","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1399-0004.2010.01555.x","article-title":"Aberrant PKD2 splicing due to a presumed novel missense mutation in autosomal-dominant polycystic kidney disease","volume":"80","author":"Tan","year":"2011","journal-title":"Clin Genet"},{"key":"10.1016\/j.cancergen.2015.11.002_bib0090","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1158\/1078-0432.CCR-13-2173","article-title":"MET is a potential target across all papillary renal cell carcinomas: result from a large molecular study of pRCC with CGH array and matching gene expression array","volume":"20","author":"Albiges","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cancergen.2015.11.002_bib0095","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.5858\/2003-127-1176-MPRTWE","article-title":"Malignant papillary renal tumors with extensive clear cell change: a molecular analysis by microsatellite analysis and fluorescence in situ hybridization","volume":"127","author":"Salama","year":"2003","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.cancergen.2015.11.002_bib0100","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1074\/jbc.271.7.3615","article-title":"Activation of hepatocyte growth factor in the injured tissues is mediated by hepatocyte growth factor activator","volume":"271","author":"Miyazawa","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cancergen.2015.11.002_bib0105","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s10689-012-9542-6","article-title":"Novel germline c-MET mutation in a family with hereditary papillary renal carcinoma","volume":"11","author":"Wadt","year":"2012","journal-title":"Fam Cancer"},{"key":"10.1016\/j.cancergen.2015.11.002_bib0110","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.cancergen.2011.06.001","article-title":"Clinical genomics of renal epithelial tumors","volume":"204","author":"Hagenkord","year":"2011","journal-title":"Cancer Genet"},{"key":"10.1016\/j.cancergen.2015.11.002_bib0115","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0002-9440(10)65147-4","article-title":"Hereditary and sporadic papillary renal carcinomas with c-met mutations share a distinct morphological phenotype","volume":"155","author":"Lubensky","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cancergen.2015.11.002_bib0120","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/(SICI)1097-0215(19990827)82:5<640::AID-IJC4>3.0.CO;2-6","article-title":"Novel mutation in the ATP-binding site of the MET oncogene tyrosine kinase in a HPRCC family","volume":"82","author":"Olivero","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cancergen.2015.11.002_bib0125","first-page":"271","article-title":"Germline and somatic c-met mutations in multifocal\/bilateral and sporadic papillary renal carcinomas of selected patients","volume":"33","author":"Salvi","year":"2008","journal-title":"Int J Oncol"},{"key":"10.1016\/j.cancergen.2015.11.002_bib0130","first-page":"7025","article-title":"Novel somatic mutations of the MET oncogene in human carcinoma metastases activating cell motility and invasion","volume":"62","author":"Lorenzato","year":"2002","journal-title":"Cancer Res"},{"issue":"1 suppl","key":"10.1016\/j.cancergen.2015.11.002_bib0135","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1177\/1758834011422556","article-title":"An overview of the c-MET signaling pathway","volume":"3","author":"Organ","year":"2011","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.cancergen.2015.11.002_bib0140","doi-asserted-by":"crossref","first-page":"9103","DOI":"10.1073\/pnas.87.23.9103","article-title":"Tissue-specific transformation by epidermal growth factor receptor: a single point mutation within the ATP-binding pocket of the erbB product increases its intrinsic kinase activity and activates its sarcomagenic potential","volume":"87","author":"Shu","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cancergen.2015.11.002_bib0145","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1042\/BJ20121365","article-title":"Assessing the range of kinase autoinhibition mechanisms in the insulin receptor family","volume":"448","author":"Artim","year":"2012","journal-title":"Biochem J"},{"key":"10.1016\/j.cancergen.2015.11.002_bib0150","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1073\/pnas.0600048103","article-title":"Structural characterization of autoinhibited c-Met kinase produced by coexpression in bacteria with phosphatase","volume":"103","author":"Wang","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cancergen.2015.11.002_bib0155","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.uct.2009.01.001","article-title":"The MET axis as a therapeutic target","volume":"3","author":"Sattler","year":"2009","journal-title":"Update Cancer Ther"},{"key":"10.1016\/j.cancergen.2015.11.002_bib0160","doi-asserted-by":"crossref","first-page":"588","DOI":"10.2183\/pjab.86.588","article-title":"The discovery of hepatocyte growth factor (HGF) and its significance for cell biology, life sciences and clinical medicine","volume":"86","author":"Nakamura","year":"2010","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"10.1016\/j.cancergen.2015.11.002_bib0165","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nrm3012","article-title":"MET signalling: principles and functions in development, organ regeneration and cancer","volume":"11","author":"Trusolino","year":"2010","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.cancergen.2015.11.002_bib0170","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.3390\/cancers6041890","article-title":"Mechanisms of hepatocyte growth factor activation in cancer tissues","volume":"6","author":"Kawaguchi","year":"2014","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cancergen.2015.11.002_bib0175","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.bbadis.2010.11.005","article-title":"Cyclic AMP-mediated cyst expansion","volume":"1812","author":"Wallace","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.cancergen.2015.11.002_bib0180","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1046\/j.1523-1755.2000.00849.x","article-title":"Time to treat polycystic kidney diseases like the neoplastic disorders that they are","volume":"57","author":"Grantham","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.cancergen.2015.11.002_bib0185","doi-asserted-by":"crossref","first-page":"c25","DOI":"10.1159\/000334166","article-title":"Mechanism-based therapeutics for autosomal dominant polycystic kidney disease: recent progress and future prospects","volume":"120","author":"Chang","year":"2012","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.cancergen.2015.11.002_bib0190","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","article-title":"Tolvaptan in patients with autosomal dominant polycystic kidney disease","volume":"367","author":"Torres","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cancergen.2015.11.002_bib0195","doi-asserted-by":"crossref","first-page":"e55119","DOI":"10.1371\/journal.pone.0055119","article-title":"The spectrum of SWI\/SNF mutations, ubiquitous in human cancers","volume":"8","author":"Shain","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cancergen.2015.11.002_bib0200","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1681\/ASN.2010030328","article-title":"What is the role of somatic mutation in autosomal dominant polycystic kidney disease?","volume":"21","author":"Harris","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.cancergen.2015.11.002_bib0205","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0140-6736(07)60601-1","article-title":"Autosomal dominant polycystic kidney disease","volume":"369","author":"Torres","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.cancergen.2015.11.002_bib0210","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S1097-2765(00)80135-5","article-title":"Somatic mutation in individual liver cysts supports a two-hit model of cystogenesis in autosomal dominant polycystic kidney disease","volume":"2","author":"Watnick","year":"1998","journal-title":"Mol Cell"},{"key":"10.1016\/j.cancergen.2015.11.002_bib0215","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1172\/JCI119147","article-title":"Loss of the polycystic kidney disease (PKD1) region of chromosome 16p13 in renal cyst cells supports a loss-of-function model for cyst pathogenesis","volume":"99","author":"Brasier","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cancergen.2015.11.002_bib0220","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.2215\/CJN.02020309","article-title":"Renal cystic diseases and renal neoplasms: a mini-review","volume":"4","author":"Bonsib","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.cancergen.2015.11.002_bib0225","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.urology.2011.01.007","article-title":"Incidence, predictors and associated outcomes of renal cell carcinoma in long-term dialysis patients","volume":"77","author":"Hurst","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.cancergen.2015.11.002_bib0230","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1681\/ASN.V491661","article-title":"Renal cell carcinoma in autosomal dominant polycystic kidney disease","volume":"4","author":"Keith","year":"1994","journal-title":"J Am Soc Nephrol"}],"container-title":["Cancer Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776215002306?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776215002306?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T20:21:52Z","timestamp":1718223712000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210776215002306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":45,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S2210776215002306"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergen.2015.11.002","relation":{},"ISSN":["2210-7762"],"issn-type":[{"value":"2210-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Papillary renal cell carcinoma with a somatic mutation in MET in a patient with autosomal dominant polycystic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Cancer Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cancergen.2015.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}